Daas Increase Serum Vegf Level: A Rationale For Tumour Risk Recurrence During Anti-Hcv TreatmentR. Villani,Antonio Facciorusso,F. Bellanti,R. Tamborra,A. Piscazzi,M. Landriscina,Gianluigi Vendemiale,Gaetano ServiddioJOURNAL OF HEPATOLOGY(2017)引用 1|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要